Felodipine
- Product NDC
- 58657-685
- 11-digit product format
- 586570685
- Labeler code
- 58657
- Product ID
- 58657-685_edb5a034-005c-54e3-e053-2995a90a5686
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Felodipine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Method Pharmacueticals, LLC
- Application
- ANDA210847
- Marketing category
- ANDA
- Marketing start
- 2020-08-12
- Marketing end
- 2022-12-31
- Substance
- FELODIPINE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58657-685-01 | 58657068501 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (58657-685-01) | 2020-08-12 | 0000-00-00 | No | No | Current |
| 58657-685-50 | 58657068550 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (58657-685-50) | 2020-08-12 | 0000-00-00 | No | No | Current |